Clinical Trial Detail

NCT ID NCT02575781
Title A Study of SAR428926 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Sanofi
Indications

colorectal cancer

stomach cancer

Advanced Solid Tumor

lung non-small cell carcinoma

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

prostate cancer

ovarian cancer

Therapies

SAR428926

Age Groups: adult

Additional content available in CKB BOOST